Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Endometrial Neoplasms 2Breast Neoplasms 2Breast Carcinoma In Situ 2Paget's Disease, Mammary 1Hot Flashes 1Endometrial Adenocarcinoma 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1

Interventions

Tamoxifen 3Radiotherapy 3Magnetic Resonance Spectroscopy 2Chemotherapy, Adjuvant 2Steroids 1Risedronic Acid 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Pharmacogenomic Testing 1Medroxyprogesterone 1Gene Expression Profiling 1Cholecalciferol 1Brachytherapy 1Anastrozole 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Carcinoma, Intraductal, Noninfiltrating × Medroxyprogesterone × Clear all
NCT00002920 2012-10-31

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

SWOG Cancer Research Network

Phase 3 Completed
313 enrolled
BreastGynecologic

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Paget's Disease, Mammary, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡